OneMedNet Launches Palantir-Powered iRWD Platform Serving 80M Patients, Secures Two Subscriptions
OneMedNet’s iRWD platform on Palantir Foundry now offers searchable access to 251 million studies across 80 million patient journeys, a ~70% network increase and linkage to 47 million tokenized patients via Datavant. The company has secured two new iRWD subscriptions and aims to convert its expanding pipeline into ARR opportunities.
1. Platform Deployment and Scale
OneMedNet’s iRWD platform, built on Palantir Foundry, is now fully operational, enabling sub-second searches across billions of clinical records. This deployment delivers instant access to multi-modal data for life sciences organizations seeking decision-grade real-world evidence at scale.
2. Network Growth and Data Linkage
The network expanded by approximately 70%, reaching 80 million patients and 251 million studies, and now includes linkage to 47 million tokenized patients via Datavant. This integration allows seamless connection of clinical, claims, genomics and mortality data for deeper longitudinal analysis.
3. Commercial Milestones and ARR Focus
OneMedNet has contracted two new customers for its iRWD platform and is actively converting a growing pipeline into subscription-based agreements. The company is targeting high-margin annual recurring revenue through expanded commercial execution and long-term customer relationships.